CMS ACCESS Model Surge: Over 150 Digital Health Players Approved for Medicare's Chronic Care Experiment

The Center for Medicare and Medicaid Innovation (CMMI) has provisionally approved more than 150 companies and providers for its experimental ACCESS model, a number that officials say 'exceeded expectations.' This signals strong market appetite for a new payment structure that ties reimbursement directly to measurable health outcomes for chronic conditions, rather than paying for individual technology services. The program aims to expand access to technology-supported chronic care management.

The approved participants include a wide spectrum of the digital health ecosystem: popular mental health apps, wearable device makers, a life sciences company tied to Google, and startups focused on helping large health systems manage conditions like heart failure. The ACCESS model will pay set rates to treat a range of chronic conditions, including diabetes, hypertension, high cholesterol, musculoskeletal pain, anxiety, and depression. The model's design, with its modest payment rates and specific restrictions, was initially seen as a potential deterrent, but the application volume suggests otherwise.

The high participation level places significant scrutiny on the program's upcoming implementation phase. Its success or failure will be a critical test of whether value-based payment models can effectively scale in digital health and drive better patient outcomes outside traditional fee-for-service structures. The performance of these 150+ entities will be closely watched by investors, policymakers, and health systems as a bellwether for the future of federally funded, tech-enabled chronic disease management.